Cardlytics (CDLX) Director John L. Klinck Receives RSU Award

What Happened John L. Klinck Jr., a director of Cardlytics, received an award of 2,200 restricted stock units (RSUs) on May 20, 2026. The award is recorded as a derivative grant at $0.00 per share (no cash exchanged). The RSUs represent a contingent right to receive one share of Cardlytics common stock (or, at the company’s election, cash) upon vesting.

Key Details

• Transaction date: May 20, 2026; Grant (A) of 2,200 RSUs at $0.00 (derivative award).
• Filing: This is an amended Form 4 filed Aug 24, 2026 correcting the originally reported RSU amount; the original Form 4 (filed May 21, 2026) had an incorrect share count.
• Reverse split adjustment: The reported RSU count has been adjusted for a 1-for-10 reverse stock split effective June 5, 2026 (see footnote).
• Vesting: RSUs vest in full on the one-year anniversary of the grant, provided Klinck remains a director on that date.
• Shares owned after transaction: Not specified in this amendment.
• Exhibit/remark: Exhibit 24 (Power of Attorney) included. The amendment indicates a correction rather than a new economic transaction.

Context This was a standard equity award to a director, not a market purchase or sale. RSU grants are a form of compensation and do not involve immediate cash proceeds; the eventual value depends on Cardlytics’ stock price at vesting. The filing was amended to correct the reported quantity and to reflect the post–reverse-split share count.